Raymond James upgraded HealthEquity (HQY) to Strong Buy from Outperform with a price target of $115, down from $120. The firm upgrade the ...
Raymond James downgraded Mural Oncology (MURA) to Outperform from Strong Buy with a price target of $6, down from $18, after the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback